The United Laboratories International Holdings Limited (ULIHF)
OTHER OTC:ULIHF
Want to see ULIHF full AI Analyst Report?
Total Valuation
The United Laboratories International Holdings has a market cap or net worth of $2.49B. The enterprise value is $10.71B.
Market Cap$2.49B
Enterprise Value$10.71B
Share Statistics
The United Laboratories International Holdings has 1,973,026,500 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding1,973,026,500
Owned by Insiders―
Owned by Institutions0.08%
Financial Efficiency
The United Laboratories International Holdings’s return on equity (ROE) is 0.12 and return on invested capital (ROIC) is 7.93%.
Return on Equity (ROE)0.12
Return on Assets (ROA)0.07
Return on Invested Capital (ROIC)7.93%
Return on Capital Employed (ROCE)0.11
Revenue Per Employee756.98K
Profits Per Employee148.70K
Employee Count17,000
Asset Turnover0.42
Inventory Turnover3.16
Valuation Ratios
The current PE Ratio of The United Laboratories International Holdings is 41.4. The United Laboratories International Holdings’s PEG ratio is -0.37.
PE Ratio41.4
PS Ratio1.52
PB Ratio1.13
Price to Fair Value1.13
Price to FCF22.94
Price to Operating Cash Flow14.62
PEG Ratio-0.37
Income Statement
In the last 12 months, The United Laboratories International Holdings had revenue of 12.87B and earned 2.03B in profits. Earnings per share was 1.08.
Revenue12.87B
Gross Profit5.37B
Operating Income2.21B
Pretax Income2.46B
Net Income2.03B
EBITDA2.84B
Earnings Per Share (EPS)1.08
Cash Flow
In the last 12 months, operating cash flow was 1.76B and capital expenditures -1.14B, giving a free cash flow of 620.04M billion.
Operating Cash Flow1.76B
Free Cash Flow620.04M
Free Cash Flow per Share0.31
Dividends & Yields
The United Laboratories International Holdings pays an annual dividend of $0.022, resulting in a dividend yield of 2.82%
Dividend Per Share$0.022
Dividend Yield2.82%
Payout Ratio25.87%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-0.27
52-Week Price Change-6.30%
50-Day Moving Average1.59
200-Day Moving Average1.79
Relative Strength Index (RSI)37.21
Average Volume (3m)0.00
Important Dates
The United Laboratories International Holdings upcoming earnings date is Sep 1, 2026, TBA (Confirmed).
Last Earnings DateMar 24, 2026
Next Earnings DateSep 1, 2026
Ex-Dividend Date―
Financial Position
The United Laboratories International Holdings as a current ratio of 1.83, with Debt / Equity ratio of 28.70%
Current Ratio1.83
Quick Ratio1.60
Debt to Market Cap0.25
Net Debt to EBITDA-2.20
Interest Coverage Ratio32.56
Taxes
In the past 12 months, The United Laboratories International Holdings has paid 435.31M in taxes.
Income Tax435.31M
Effective Tax Rate0.18
Enterprise Valuation
The United Laboratories International Holdings EV to EBITDA ratio is 4.70, with an EV/FCF ratio of 15.64.
EV to Sales1.04
EV to EBITDA4.70
EV to Free Cash Flow15.64
EV to Operating Cash Flow3.57
Balance Sheet
The United Laboratories International Holdings has $11.24B in cash and marketable securities with $4.99B in debt, giving a net cash position of $6.25B billion.
Cash & Marketable Securities$11.24B
Total Debt$4.99B
Net Cash$6.25B
Net Cash Per Share$3.17
Tangible Book Value Per Share$9.17
Margins
Gross margin is 41.84%, with operating margin of 17.18%, and net profit margin of 15.79%.
Gross Margin41.84%
Operating Margin17.18%
Pretax Margin19.14%
Net Profit Margin15.79%
EBITDA Margin22.10%
EBIT Margin17.18%
Analyst Forecast
The average price target for The United Laboratories International Holdings is $2.09, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$2.09
Price Target Upside10.92% Upside
Analyst ConsensusStrong Buy
Analyst Count5
Revenue Growth Forecast-3.99%
EPS Growth Forecast-22.63%